Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.
中东呼吸综合征冠状病毒病毒载体候选疫苗的安全性和免疫原性：剂量递增、开放标签、非随机、非对照的 1 期试验
期刊:Lancet Infectious Diseases
影响因子:31
doi:10.1016/S1473-3099(20)30160-2
Folegatti Pedro M, Bittaye Mustapha, Flaxman Amy, Lopez Fernando Ramos, Bellamy Duncan, Kupke Alexandra, Mair Catherine, Makinson Rebecca, Sheridan Jonathan, Rohde Cornelius, Halwe Sandro, Jeong Yuji, Park Young-Shin, Kim Jae-Ouk, Song Manki, Boyd Amy, Tran Nguyen, Silman Daniel, Poulton Ian, Datoo Mehreen, Marshall Julia, Themistocleous Yrene, Lawrie Alison, Roberts Rachel, Berrie Eleanor, Becker Stephan, Lambe Teresa, Hill Adrian, Ewer Katie, Gilbert Sarah
